• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CERENOVUS, INC. GALAXY G3 XSFT 2MM X 2CM; NEUROVASCULAR EMBOLIZATION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CERENOVUS, INC. GALAXY G3 XSFT 2MM X 2CM; NEUROVASCULAR EMBOLIZATION DEVICE Back to Search Results
Model Number GLX120202
Medical Device Problem Code Separation Failure (2547)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/25/2023
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Product complaint #: (b)(4).Information regarding patient weight, height, medical history, race, and ethnicity was not reported.Section e1 ¿ initial reporter: the customer contact information, including name, occupation, phone, fax, and e-mail address, was not reported.The device was discarded, therefore, no further investigation can be performed.A manufacturing record evaluation was performed for the finished device 30670797 number, and no non-conformances related to the malfunction were identified.Missing information from this report is identified as blank; this information was not provided in the reported event or available at the time of report submission.The company is seeking this information through the event investigation.This report is being submitted pursuant to the provisions of 21 cfr, part 803 (and/or part 4, as applicable).This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by cerenovus, or its employees that the report constitutes an admission that the product, cerenovus, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.A supplemental report will be submitted if new facts arise which materially alter information submitted in a previous mdr report.
 
Event or Problem Description
As reported by the field, this was a coil embolization for major aoetopulmonary collateral arteries (mapca) post pediatric procedure.After microcatheter was inserted to ima, the galaxy g3 xsft 2mm x 2cm (glx120202, 30670797) was approached as a first coil.When attempted to detach, it could not.Replacing the enpowercontrolcable (ecb00018200, 30960241), but the issue continued.Pulled the coil outside the patient, and was able to detach.After approaching the second coil and attempted to detach, but it could not be detached.The issue was resolved by replacing the dcb2 control box, and the procedure was completed with about 10 coils used.There was no negative impact to the patient.A continuous flush was not done.The lesion was internal mammary artery.Other concomitant devices are marvel microcatheter.
 
Additional Manufacturer Narrative
Product complaint (b)(4).Section b5: additional information received, indicated that a pre-deployment electrical testing was performed.The same dcb was not used successfully with subsequent coils.No neck remodeling was utilized.The coil was still attached to the coil delivery system when removed from the patient.The coil did not become stretched or damaged when removed.Section e1.: initial reporter phone: (b)(6).Complaint conclusion: as reported, by the field.This was a coil embolization, for major aoetopulmonary collateral arteries (mapca), post pediatric procedure.After the microcatheter was inserted to internal mammary artery (ima), the galaxy g3 xsft 2mm x 2cm (glx120202, 30670797) was approached, as a first coil.When attempted to detach, it could not.Replacing the empower control cable ((b)(4), 30960241), but the issue continued.Pulled the coil outside the patient and was able to detach.After approaching, the second coil and attempted to detach, but it could not be detached.The issue was resolved, by replacing the dcb2 control box.And the procedure was completed with about 10 coils used.There was no negative impact to the patient.A continuous flush was not done.The lesion was internal mammary artery.Other concomitant devices: are marvel microcatheter.Additional information was received.Indicating, that a pre-deployment electrical testing was performed.The same dcb was not used successfully with subsequent coils.No neck remodeling was utilized.The coil was still attached to the coil delivery system, when removed from the patient.The coil did not become stretched or damaged when removed.The device was discarded.Therefore, no further investigation can be performed.A manufacturing record evaluation was performed for the finished device 30670797 number.And no non-conformances related to the malfunction were identified.Failure to detach, is a known potential issue associated with the use of this device.The instructions for use (ifu) contains several precautions related to this issue.And includes instructions for troubleshooting, the situation should it be encountered during use.With the information available and without the product available for analysis, the reported customer complaint could not be confirmed.Based on the manufacturing record evaluation, there is no indication, that the event is related to the device manufacturing process.The exact cause of the event could not be determined.However, there are circumstances of the procedure that may have contributed to the reported failure.As part of the post market surveillance program, information from this complaint is trended to identify statistical signals for consideration of further correction action.Since, there was no evidence to suggest the event was related to a manufacturing or design issue, no corrective actions will be taken at this time.A supplemental report will be submitted, if new facts arise, which materially alter information submitted in a previous mdr report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GALAXY G3 XSFT 2MM X 2CM
Common Device Name
NEUROVASCULAR EMBOLIZATION DEVICE
Manufacturer (Section D)
CERENOVUS, INC.
6303 waterford district drive
suites 215 & 315
miami FL 33126
Manufacturer (Section G)
CERENOVUS INC. (FREMONT)
47709 fremont blvd
fremont CA 94538
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
3035526892
MDR Report Key17106716
Report Number3008114965-2023-00375
Device Sequence Number11499241
Product Code KRD
UDI-Device Identifier10886704077640
UDI-Public10886704077640
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K150319
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 07/07/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date09/30/2024
Device Model NumberGLX120202
Device Catalogue NumberGLX120202
Device Lot Number30670797
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/25/2023
Supplement Date Received by Manufacturer07/07/2023
Initial Report FDA Received Date06/12/2023
Supplement Report FDA Received Date07/07/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured10/14/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ENPOWER CONTROL CABLE; ENPOWER DCB 2; MARVEL MICROCATHETER
Patient SexUnknown
-
-